Abstract

Ubiquitously expressed membrane type-1 matrix metalloproteinase (MT1-MMP), an archetype member of the MMP family, binds tissue inhibitor of metalloproteinases-2 (TIMP-2), activates matrix metalloproteinase-2 (MMP-2), and stimulates cell migration in various cell types. In contrast with MT1-MMP, the structurally similar MT6-MMP associates with the lipid raft compartment of the plasma membrane using a GPI anchor. As a result, MT6-MMP is functionally distinct from MT1-MMP. MT6-MMP is insufficiently characterized as yet. In addition, a number of its biochemical features are both conflicting and controversial. To reassess the biochemical features of MT6-MMP, we have expressed the MT6-MMP construct tagged with a FLAG tag in breast carcinoma MCF-7 and fibrosarcoma HT1080 cells. We then used phosphatidylinositol-specific phospholipase C to release MT6-MMP from the cell surface and characterized the solubilized MT6-MMP fractions. We now are confident that cellular MT6-MMP partially exists in its complex with TIMP-2. Both TIMP-1 and TIMP-2 are capable of inhibiting the proteolytic activity of MT6-MMP. MT6-MMP does not stimulate cell migration. MT6-MMP, however, generates a significant level of gelatinolysis of the fluorescein isothiocyanate-labeled gelatin and exhibits an intrinsic, albeit low, ability to activate MMP-2. As a result, it is exceedingly difficult to record the activation of MMP-2 by cellular MT6-MMP. Because of its lipid raft localization, cellular MT6-MMP is inefficiently internalized. MT6-MMP is predominantly localized in the cell-to-cell junctions. Because MT6-MMP has been suggested to play a role in disease, including cancer and autoimmune multiple sclerosis, the identity of its physiologically relevant cleavage targets remains to be determined.

Highlights

  • Org. 2 The abbreviations used are: MMP, matrix metalloproteinase; at Molecular Probes. Human ␣1-antitrypsin (AAT), ␣1-antitrypsin; GPI, glycosylphosphatidylinositol; DAPI, 4Ј,6-diamidino-2phenylindole; EZ-link sulfo-NHS-SS-biotin, sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate; HT cells, human fibrosarcoma HT1080 cells; Mca-PLGL-Dpa-AR-NH2, methoxycoumarin-4-yl)-acetylPro-Leu-Gly-Leu-(3-[2,4-dinitrophenyl]-l-2,3-diaminopropionyl)-Ala-ArgNH2; MCF7 cells, human breast carcinoma MCF-7 cells; Mercaptoethane Sulfonic Acid (MESNA), 2-mercaptoethane sulfonic acid; MT-MMP, membrane-type MMP; membrane type-1 matrix metalloproteinase (MT1-MMP) and MT6-MMP, membrane type-1 and membrane type-6 MMP, respectively; growth factors, and cell receptors and play important roles in multiple diseases [1,2,3]

  • Recombinant tissue inhibitors of MMPs (TIMPs)-2 and the TIMP-2-free matrix metalloproteinase-2 (MMP-2) proenzyme were isolated from the conditioned medium of CHO cells and p2AHT2A72 cells, respectively. p2AHT2A72 cells were derived from the fibrosarcoma HT1080 cell line sequentially transfected with E1A and MMP-2 cDNAs, respectively [22, 23]

  • There was conflicting evidence about the ability of MT6MMP to be regulated by TIMPs, to play a role in the activation of MMP-2, and to support cell migration

Read more

Summary

Introduction

Org. 2 The abbreviations used are: MMP, matrix metalloproteinase; AAT, ␣1-antitrypsin; GPI, glycosylphosphatidylinositol; DAPI, 4Ј,6-diamidino-2phenylindole; EZ-link sulfo-NHS-SS-biotin, sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate; HT cells, human fibrosarcoma HT1080 cells; Mca-PLGL-Dpa-AR-NH2, methoxycoumarin-4-yl)-acetylPro-Leu-Gly-Leu-(3-[2,4-dinitrophenyl]-l-2,3-diaminopropionyl)-Ala-ArgNH2; MCF7 cells, human breast carcinoma MCF-7 cells; MESNA, 2-mercaptoethane sulfonic acid; MT-MMP, membrane-type MMP; MT1-MMP and MT6-MMP, membrane type-1 and membrane type-6 MMP, respectively; growth factors, and cell receptors and play important roles in multiple diseases [1,2,3]. MMPs, especially membrane-type MMPs (MT-MMPs), have been proposed to play key roles in tumor invasion and metastasis [4]. MT1-MMP, MT2-MMP, MT3MMP, and MT5-MMP are anchored to the plasma membrane via a transmembrane domain [1, 4]. There is a significant level of knowledge of the structural-functional relationships and regulation of MT1-MMP, an archetype member of the subfamily, exceedingly little is known about the biochemical and cellular properties of GPI-linked MT4-MMP and especially MT6-MMP. MT6-MMP is a membrane proteinase with an extracellular prodomain followed by the catalytic domain, the hinge region, the hemopexin domain, the stalk region, and a GPI anchor attached to the carboxyl end of the stalk. The relevance of MT6-MMP proteolysis of these target proteins to the enzyme functionality in both normal development and disease progression, is not entirely clear as of

Objectives
Methods
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.